Eileen Flynn
About Eileen Flynn
Eileen Flynn serves as the Senior Director of Quality Assurance at Calithera Biosciences, a position she has held since 2018. She has extensive experience in the biotechnology sector, having previously worked in senior roles at Genentech and Exelixis.
Work at Calithera Biosciences
Eileen Flynn has been serving as the Senior Director of Quality Assurance at Calithera Biosciences since 2018. In this role, she is responsible for overseeing quality assurance processes and ensuring compliance with regulatory standards. Her leadership contributes to the development and implementation of quality systems that support the company's mission in the biopharmaceutical sector. Calithera Biosciences is based in San Francisco, California, where Flynn plays a key role in maintaining product quality and safety.
Previous Experience at Genentech
Prior to her current position, Eileen Flynn worked at Genentech as a Senior Technical Manager from 2004 to 2009. During her five years at Genentech, she focused on technical management within the quality assurance domain. Her experience at this leading biotechnology company provided her with a strong foundation in quality systems and regulatory compliance, which she later applied in her subsequent roles.
Experience at Exelixis
Eileen Flynn served as the Executive Director of Quality Assurance at Exelixis from 2009 to 2017. In this capacity, she led quality assurance initiatives and developed strategies to ensure product quality and regulatory compliance. Her eight years at Exelixis enhanced her expertise in managing quality systems in the biopharmaceutical industry, preparing her for her current leadership role.
Education and Expertise
Eileen Flynn earned her Master of Science degree from the University of San Francisco, where she studied from 1998 to 2001. She also holds a Bachelor of Science degree from the University of California, Davis. Her educational background provides her with a solid foundation in scientific principles, which supports her work in quality assurance and regulatory compliance in the biopharmaceutical field.